Pharmaceutical

Wed, 30/08/2017 - 15:30
London, UK, 25th August 2017 / Sciad Newswire / Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial
Thu, 29/06/2017 - 07:30
Australian immuno-oncology company Minomic International Ltd is proceeding to the second stage of its pioneering MILGa clinical trial of MiltuximabTM, a chimeric version of Minomic’s MIL-38 anti-Glypican1 antibody conjugated to the radioactive isotope 67Gallium.
Mon, 26/06/2017 - 07:30
Coventry, UK, 26th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nex
Thu, 22/06/2017 - 07:00
First acquisition made by Invent Farma / neuraxpharm following the creation of the Group by funds advised by Apax Partners in August 2016
Wed, 14/06/2017 - 07:30
Domainex Ltd. expands its partnership with Imperial College London, to discover novel therapies that reduce heart muscle damage during heart attacks. ​
Mon, 12/06/2017 - 07:30
Coventry, UK, 12th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nov
Tue, 06/06/2017 - 07:30
Coventry, UK, 6th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nove
Wed, 17/05/2017 - 13:00
New, fully integrated systems to include data reporting and visualization, reproduction of assay workflows, ELN and registration tools
Mon, 08/05/2017 - 07:30
Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel

Pages